Adjuvant Nivolumab (NIVO) Vs Ipilimumab (IPI) in Resected Stage III/IV Melanoma: 7-Y Results from CheckMate 238P. A. Ascierto,M. Del Vecchio,B. Merelli,H. Gogas,A. M. Arance Fernandez,S. Dalle,C. L. Cowey,M. Schenker,J. J. Grob,V. Chiarion Sileni,I. Marquez-Rodas,M. O. Butler,A. M. Di Giacomo,M. Pe Benito,R. Soomro,M. Askelson,J. S. Weber,J. LarkinANNALS OF ONCOLOGY（2023）引用 0|浏览14AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
